YOSHIKAWA Masahiro
| School of Medicine Department of Medicine | Research Assistant |
Researcher Information
Research activity information
Paper
- Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers
Masahiro Yoshikawa; Tomohiro Nakayama; Kensuke Asaba
Communications Biology, Dec. 2024, Refereed
Lead - CCN3/NOV as a potential therapeutic target for diverticular disease: A proteome-wide Mendelian randomization study
Masahiro Yoshikawa; Kensuke Asaba
Medicine (Baltimore), Nov. 2024, Refereed, Not invited
Lead - Prioritization of nasal polyp associated genes by integrating GWAS and eQTL summary data
Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
Frontiers in Genetics, Jun. 2023, Refereed, Not invited
Lead - Estimating causal effects of genetically predicted type 2 diabetes on COVID-19 in the East Asian population
Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
Frontiers in Endocrinology, Dec. 2022, Refereed, Not invited
Lead - Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study
Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
PLOS ONE, Dec. 2021, Refereed, Not invited
Lead - Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach
Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
BMC Medical Genomics, Nov. 2021, Refereed, Not invited
Lead - Educational Attainment Decreases the Risk of COVID-19 Severity in the European Population: A Two-Sample Mendelian Randomization Study
Masahiro Yoshikawa; Kensuke Asaba
Frontiers in Public Health, Jun. 2021, Refereed
Lead - The APLNR gene polymorphism rs7119375 is associated with an increased risk of development of essential hypertension in the Chinese population: A meta-analysis.
Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
Medicine (Baltimore), Dec. 2020, Refereed
Lead - Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis
Masahiro Yoshikawa; Kensuke Asaba
Scientific Reports, Aug. 2020, Refereed, Not invited
Lead - Long-term effects of low calcium dialysates on the serum calcium levels during maintenance hemodialysis treatments: A systematic review and meta-analysis.
Masahiro Yoshikawa; Osamu Takase; Taro Tsujimura; Etsuko Sano; Matsuhiko Hayashi; Tsuyoshi Takato; Keiichi Hishikawa
Scientific reports, Mar. 2018, Refereed, Not invited
Lead - Trichostatin a prevents TGF-β1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells
Masahiro Yoshikawa; Keiichi Hishikawa; Mana Idei; Toshiro Fujita
European Journal of Pharmacology, Jun. 2010, Refereed, Not invited
Lead - Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta 1 in human renal epithelial cells.
Masahiro Yoshikawa; Keiichi Hishikawa; Takeshi Marumo; Toshiro Fujita
Journal of the American Society of Nephrology, Jan. 2007, Refereed, Not invited
Lead
MISC
- Controlling gene activation by enhancers through a drug-inducible topological insulator.
Taro Tsujimura; Osamu Takase; Masahiro Yoshikawa; Etsuko Sano; Matsuhiko Hayashi; Kazuto Hoshi; Tsuyoshi Takato; Atsushi Toyoda; Hideyuki Okano; Keiichi Hishikawa
eLife, 05 May 2020 - Control of directionality of chromatin folding for the inter- and intra-domain contacts at the Tfap2c-Bmp7 locus.
Taro Tsujimura; Osamu Takase; Masahiro Yoshikawa; Etsuko Sano; Matsuhiko Hayashi; Tsuyoshi Takato; Atsushi Toyoda; Hideyuki Okano; Keiichi Hishikawa
Epigenetics & chromatin, 14 Sep. 2018 - Roles and regulation of bone morphogenetic protein-7 in kidney development and diseases.
Taro Tsujimura; Mana Idei; Masahiro Yoshikawa; Osamu Takase; Keiichi Hishikawa
World journal of stem cells, 26 Sep. 2016 - Adult stem-like cells in kidney.
Keiichi Hishikawa; Osamu Takase; Masahiro Yoshikawa; Taro Tsujimura; Masaomi Nangaku; Tsuyoshi Takato
World journal of stem cells, 26 Mar. 2015 - The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells.
Osamu Takase; Masahiro Yoshikawa; Mana Idei; Junichi Hirahashi; Toshiro Fujita; Tsuyoshi Takato; Takayuki Isagawa; Genta Nagae; Hirofumi Suemori; Hiroyuki Aburatani; Keiichi Hishikawa
PloS one, 2013 - Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
Takeshi Marumo; Keiichi Hishikawa; Masahiro Yoshikawa; Junichi Hirahashi; Shoji Kawachi; Toshiro Fujita
American journal of physiology. Renal physiology, Jan. 2010 - Epigenetic regulation of BMP7 in the regenerative response to ischemia.
Takeshi Marumo; Keiichi Hishikawa; Masahiro Yoshikawa; Toshiro Fujita
Journal of the American Society of Nephrology : JASN, Jul. 2008 - Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension.
Makiko Kido; Katsuyuki Ando; Maristela L Onozato; Akihiro Tojo; Masahiro Yoshikawa; Teruhiko Ogita; Toshiro Fujita
Hypertension (Dallas, Tex. : 1979), Feb. 2008 - Musculin/MyoR is expressed in kidney side population cells and can regulate their function.
Keiichi Hishikawa; Takeshi Marumo; Shigeki Miura; Asato Nakanishi; Yumi Matsuzaki; Katsunori Shibata; Tomoko Ichiyanagi; Hiroko Kohike; Takuya Komori; Ichiro Takahashi; Osamu Takase; Naohiko Imai; Masahiro Yoshikawa; Toshihiko Inowa; Matsuhiko Hayashi; Toshio Nakaki; Hiromitsu Nakauchi; Hideyuki Okano; Toshiro Fujita
The Journal of cell biology, 20 Jun. 2005 - 両側肺野に多発結節影を呈したPulmonary Langerhans'-Cell Histiocytosisの1例
吉川 真弘; 倉沢 忠弘; 大山 雅代; 佐藤 圭一; 佐藤 芳之; 苅家 利承; 増田 幸蔵; 井上 泰
呼吸と循環, Mar. 2002
Lead - Postsynaptic Modulation of AMPA Receptor-Mediated Synaptic Responses and LTP by the Type 3 Ryanodine Receptor
Misa Shimuta; Masahiro Yoshikawa; Masahiro Fukaya; Masahiko Watanabe; Hiroshi Takeshima; Toshiya Manabe
Molecular and Cellular Neuroscience, May 2001
Research Themes
- Development of novel kidney regeneration therapy using iPS cell-derived kidney tissue stem cells
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 01 Apr. 2015 - 31 Mar. 2018
yoshikawa masahiro - New cell therapy for kidney disease using human kidney derived iPS cells
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 28 Apr. 2011 - 31 Mar. 2015
YOSHIKAWA Masahiro; HISHIKAWA Keiichi; FUJITA Toshiro; ABRATANI Hiroyuki - Investigation of a new promising therapeutic for renal diseases by chromatin remodeling.
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 2007 - 2008
YOSHIKAWA Masahiro
